Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Hospital Essen, Essen, Germany.
Eur J Neurol. 2023 Sep;30(9):2821-2827. doi: 10.1111/ene.15852. Epub 2023 May 22.
5q Spinal muscular atrophy (SMA) is a progressive, inherited, and severely disabling - yet treatable - motor neuron disease. Although treatment options have evolved in recent years, biomarkers for treatment monitoring and prognosis prediction remain elusive. Here, we investigated the utility of corneal confocal microscopy (CCM), a non-invasive imaging technique to quantify small corneal nerve fibres in vivo, as a diagnostic tool in adult SMA.
In this cross-sectional study, 19 patients with SMA type 3 and 19 healthy controls underwent CCM to measure corneal nerve fibre density (CNFD), corneal nerve fibre length (CNFL), and corneal nerve branch density (CNBD), as well as corneal immune cell infiltration. Hammersmith Functional Motor Scale Expanded (HFMSE) and Revised Upper Limb Module (RULM) scores and a 6-Minute Walk Test (6MWT) were conducted to explore any correlation between CCM findings and motor function.
Corneal nerve fibre parameters were decreased in SMA patients versus healthy controls (CNFD: p = 0.030; CNFL: p = 0.013; CNBD: p = 0.020) in the absence of relevant immune cell infiltration. CNFD and CNFL correlated with HFMSE scores (CNFD: r = 0.492, p = 0.038; CNFL: r = 0.484, p = 0.042) and distance covered in the 6MWT (CNFD: r = 0.502, p = 0.042; CNFL: r = 0.553, p = 0.023).
Corneal confocal microscopy CCM reveals sensory neurodegeneration in SMA, thereby supporting a multisystem view of the disorder. Subclinical small nerve fibre damage correlated with motor function. Thus, CCM may be ideally suited for treatment monitoring and prognosis.
5q 型脊髓性肌萎缩症(SMA)是一种进行性的、遗传性的、严重致残但可治疗的运动神经元疾病。尽管近年来治疗选择有所发展,但治疗监测和预后预测的生物标志物仍难以捉摸。在这里,我们研究了角膜共焦显微镜(CCM)的效用,CCM 是一种非侵入性的活体量化小角膜神经纤维的成像技术,作为成人 SMA 的诊断工具。
在这项横断面研究中,19 名 SMA 3 型患者和 19 名健康对照者接受 CCM 检查,以测量角膜神经纤维密度(CNFD)、角膜神经纤维长度(CNFL)和角膜神经分支密度(CNBD)以及角膜免疫细胞浸润。进行了哈默史密斯功能性运动量表扩展(HFMSE)和修订后的上肢模块(RULM)评分以及 6 分钟步行测试(6MWT),以探讨 CCM 结果与运动功能之间的任何相关性。
与健康对照组相比,SMA 患者的角膜神经纤维参数降低(CNFD:p=0.030;CNFL:p=0.013;CNBD:p=0.020),而无相关免疫细胞浸润。CNFD 和 CNFL 与 HFMSE 评分相关(CNFD:r=0.492,p=0.038;CNFL:r=0.484,p=0.042)和 6MWT 中覆盖的距离相关(CNFD:r=0.502,p=0.042;CNFL:r=0.553,p=0.023)。
角膜共焦显微镜 CCM 显示 SMA 中的感觉神经退行性变,从而支持该疾病的多系统观点。亚临床小神经纤维损伤与运动功能相关。因此,CCM 可能非常适合治疗监测和预后。